Cited by

• Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses.

  Otten HG, de Gast GC, Vooijs WC, van der Gouw AP, de Boer M, Ossevoort MA, Jonker M. Otten HG, et al. Cancer Immunol Immunother. 2003 Sep;52(9):569-75. doi: 10.1007/s00262-003-0401-z. Cancer Immunol Immunother. 2003. PMID: 14627129 Free PMC article.
• Multiple primary enoral soft tissue manifestations of a Hodgkin lymphoma--case report and literature review.

  Kämmerer PW, Schiegnitz E, Hansen T, Draenert GF, Kuffner HD, Klein MO. Kämmerer PW, et al. Oral Maxillofac Surg. 2013 Mar;17(1):53-7. doi: 10.1007/s10006-012-0321-1. Epub 2012 Apr 18. Oral Maxillofac Surg. 2013. PMID: 22527654 Review.
• High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.

  O'Brien S, Schiller G, Lister J, Damon L, Goldberg S, Aulitzky W, Ben-Yehuda D, Stock W, Coutre S, Douer D, Heffner LT, Larson M, Seiter K, Smith S, Assouline S, Kuriakose P, Maness L, Nagler A, Rowe J, Schaich M, Shpilberg O, Yee K, Schmieder G, Silverman JA, Thomas D, Deitcher SR, Kantarjian H. O'Brien S, et al. J Clin Oncol. 2013 Feb 20;31(6):676-83. doi: 10.1200/JCO.2012.46.2309. Epub 2012 Nov 19. J Clin Oncol. 2013. PMID: 23169518 Free PMC article. Clinical Trial.
• ⁹⁰Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.

  Conlon KC, Sportes C, Brechbiel MW, Fowler DH, Gress R, Miljkovic MD, Chen CC, Whatley MA, Bryant BR, Corcoran EM, Kurdziel KA, Pittaluga S, Paik CH, Lee JH, Fleisher TA, Carrasquillo JA, Waldmann TA. Conlon KC, et al. Cancer Biother Radiopharm. 2020 May;35(4):249-261. doi: 10.1089/cbr.2019.3298. Epub 2020 Apr 9. Cancer Biother Radiopharm. 2020. PMID: 32275165 Free PMC article. Clinical Trial.
• Disparities in survival after Hodgkin lymphoma: a population-based study.

  Keegan TH, Clarke CA, Chang ET, Shema SJ, Glaser SL. Keegan TH, et al. Cancer Causes Control. 2009 Dec;20(10):1881-92. doi: 10.1007/s10552-009-9382-3. Cancer Causes Control. 2009. PMID: 19557531 Free PMC article.